These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37433582)

  • 21. Impact evaluation of a brief online training module on physician use of the Maryland, USA, Prescription Drug Monitoring Program.
    Adenaiye OO; Zirpoli JB; Tan M; Day BF; Bolaji O; Mitchell CS; Cloeren M
    PLoS One; 2022; 17(8):e0272217. PubMed ID: 35944051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.
    Bao Y; Pan Y; Taylor A; Radakrishnan S; Luo F; Pincus HA; Schackman BR
    Health Aff (Millwood); 2016 Jun; 35(6):1045-51. PubMed ID: 27269021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids.
    Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S
    Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoption of electronic medical record-based decision support for otitis media in children.
    Fiks AG; Zhang P; Localio AR; Khan S; Grundmeier RW; Karavite DJ; Bailey C; Alessandrini EA; Forrest CB
    Health Serv Res; 2015 Apr; 50(2):489-513. PubMed ID: 25287670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De-Implementing Opioids for Dental Extractions (DIODE): a multi-clinic, cluster-randomized trial of clinical decision support strategies in dentistry.
    Gryczynski J; Mitchell SG; Asche SE; Truitt AR; Worley DC; Rindal DB
    Implement Sci; 2023 Feb; 18(1):5. PubMed ID: 36765414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How prescription drug monitoring programs influence clinical decision-making: A mixed methods systematic review and meta-analysis.
    Picco L; Lam T; Haines S; Nielsen S
    Drug Alcohol Depend; 2021 Nov; 228():109090. PubMed ID: 34600255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Experimental Test of the Effectiveness of Unsolicited Reporting by a Prescription Drug Monitoring Program in Reducing Inappropriate Acquisition of Opioids.
    McDonald DC; Carlson KE; Jalbert SK
    Pain Med; 2019 May; 20(5):944-954. PubMed ID: 29868715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
    Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
    MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
    Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
    Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription drug monitoring program design and function: A qualitative analysis.
    Rutkow L; Smith KC; Lai AY; Vernick JS; Davis CS; Alexander GC
    Drug Alcohol Depend; 2017 Nov; 180():395-400. PubMed ID: 28978492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
    Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
    J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping prescription drug monitoring program data to self-report measures of non-medical prescription opioid use in community pharmacy settings.
    Charron E; Brooks JH; Peterson KT; Akinwolere OG; Winhusen T; Cochran G
    Res Social Adm Pharm; 2023 Aug; 19(8):1171-1177. PubMed ID: 37142474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers to Increasing Prescription Drug Monitoring Program Use: A Multidisciplinary Perspective.
    St Marie BJ; Witry MJ; Reist JC
    Comput Inform Nurs; 2023 Aug; 41(8):556-562. PubMed ID: 36728156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.
    Bart GB; Saxon A; Fiellin DA; McNeely J; Muench JP; Shanahan CW; Huntley K; Gore-Langton RE
    Addict Sci Clin Pract; 2020 Jan; 15(1):4. PubMed ID: 31948487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternatives to Opioid Education and a Prescription Drug Monitoring Program Cumulatively Decreased Outpatient Opioid Prescriptions.
    Sigal A; Shah A; Onderdonk A; Deaner T; Schlappy D; Barbera C
    Pain Med; 2021 Feb; 22(2):499-505. PubMed ID: 33067993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes.
    Nielsen S; Picco L; Russell G; Pearce C; Andrew NE; Lubman DI; Bell JS; Buchbinder R; Xia T
    Int J Drug Policy; 2023 Jul; 117():104053. PubMed ID: 37209441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Care Implementation of a Mandatory Prescription Drug Monitoring Program in New York City.
    Chernick R; Allen B; Harocopos A
    J Behav Health Serv Res; 2022 Apr; 49(2):122-133. PubMed ID: 34426933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. General practitioners' attitudes and preparedness towards Clinical Decision Support in e-Prescribing (CDS-eP) adoption in the West of Ireland: a cross sectional study.
    Hor CP; O'Donnell JM; Murphy AW; O'Brien T; Kropmans TJ
    BMC Med Inform Decis Mak; 2010 Jan; 10():2. PubMed ID: 20067624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.
    Fink PB; Deyo RA; Hallvik SE; Hildebran C
    Pain Med; 2018 Dec; 19(12):2481-2486. PubMed ID: 29155988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dental opioid prescribing practices and risk mitigation strategy implementation: Identification of potential targets for provider-level intervention.
    McCauley JL; Leite RS; Melvin CL; Fillingim RB; Brady KT
    Subst Abus; 2016; 37(1):9-14. PubMed ID: 26675303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.